Loading...

HCWB HCW BIOLOGICS INC Company Mergers 8-K Filing

HCW

HCWB

HCW BIOLOGICS INC

(HCWB)

2025 8-K

Show Summary

Show Summary

Voluntary Delisting

Rights Offerings

Management Changes

Asset Acquisitions

Equity Offerings

Rights Offerings

Equity Offerings

Financial Statements

Equity Offerings

Equity Agreement

Stock Split Approval

Financial Results

Agreement Amendment

Nasdaq Delisting Notice

Equity Purchase Agreement

Nasdaq Delisting Notice

Nasdaq Delisting Notice

Securities Agreement

License Agreement

Financial Results

Financial Results

Nasdaq Compliance Notice

Settlement Agreement and Re...

Delisting Notice

Annual Meeting of Stockholders

Financial Results Announcement

Criminal Fraud Event

Financial Results Announcement

Agreement for Stock Sale

Termination of Credit Agree...

Financial Results Announcement

Financial Results Announcement

Annual Meeting Results

Financial Results Announcement

Agreement for Line of Credit

Financial Results Announcement

External Links:

On May 29, 2025, HCW Biologics Inc. confirmed that WY Biotech Co., Ltd. chose to continue their exclusive licensing agreement, committing to pay a $7 million upfront licensing fee following a successful technology transfer report delivered on May 13,

AI Assistant

HCW BIOLOGICS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.